Get started
COHERUS BIOSCIEN.DL-,0001COHERUS BIOSCIEN.DL-,0001COHERUS BIOSCIEN.DL-,0001

COHERUS BIOSCIEN.DL-,0001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals Bonds

8C5 chart


Full chart

8C5 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪179.66 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0070 EUR
Net income (FY)
‪−215.53 M‬ EUR
Revenue (FY)
‪233.07 M‬ EUR
Shares float
‪110.57 M‬
Beta (1Y)
1.71

About Coherus BioSciences, Inc.


Sector
Health Technology
CEO
Denny M. Lanfear
Headquarters
Redwood City
Website
coherus.com
Founded
2010
FIGI
BBG007J27QK2
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

8C5 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

8C5 highest yielding bonds


CHRS5172388
Coherus BioSciences, Inc. 1.5% 15-APR-2026
Yield to maturity
4.09%
Maturity date
Apr 15, 2026

Explore more bonds 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange COHERUS BIOSCIEN.DL-,0001 stocks are traded under the ticker 8C5.
We've gathered analysts' opinions on COHERUS BIOSCIEN.DL-,0001 future price: according to them, 8C5 price has a max estimate of 7.61 EUR and a min estimate of 5.71 EUR. Watch 8C5 chart and read a more detailed COHERUS BIOSCIEN.DL-,0001 stock forecast: see what analysts think of COHERUS BIOSCIEN.DL-,0001 and suggest that you do with its stocks.
8C5 reached its all-time high on Jul 22, 2015 with the price of 34.9200 EUR, and its all-time low was 0.6060 EUR and was reached on Nov 5, 2024. View more price dynamics on 8C5 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track COHERUS BIOSCIEN.DL-,0001 financials in yearly and quarterly reports right on TradingView.
COHERUS BIOSCIEN.DL-,0001 is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
8C5 earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.15 EUR resulting in a 44.91% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about COHERUS BIOSCIEN.DL-,0001 earnings.
COHERUS BIOSCIEN.DL-,0001 revenue for the last quarter amounts to ‪63.57 M‬ EUR, despite the estimated figure of ‪52.97 M‬ EUR. In the next quarter, revenue is expected to reach ‪42.65 M‬ EUR.
8C5 net income for the last quarter is ‪−9.66 M‬ EUR, while the quarter before that showed ‪−12.06 M‬ EUR of net income which accounts for 19.95% change. Track more COHERUS BIOSCIEN.DL-,0001 financial stats to get the full picture.
No, 8C5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 8, 2025, the company has 306.00 employees. See our rating of the largest employees — is COHERUS BIOSCIEN.DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COHERUS BIOSCIEN.DL-,0001 EBITDA is ‪−112.87 M‬ EUR, and current EBITDA margin is −73.63%. See more stats in COHERUS BIOSCIEN.DL-,0001 financial statements.
Like other stocks, 8C5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COHERUS BIOSCIEN.DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.